CompletedNot Applicable

Expressive Storytelling to Share Adolescents/Young Adults Cancer Stories

United States15 participantsStarted 2021-11-10

Plain-language summary

The purpose of this study is to test the feasibility, acceptability, and preliminary efficacy of an online expressive storytelling intervention for adolescents and young adults (AYA) with cancer. * Specific Aim 1. To evaluate the feasibility and acceptability of a 5-week online expressive storytelling intervention. We will (a) conduct a 1-group pre- and post-test study with 20 AYA with cancer and (b) examine feasibility and acceptability through study enrollment rates, retention rates, usability score, adherence and data collection rates, satisfaction score, perceived benefits score, and intervention fidelity. \*Hypothesis 1: We will reach following feasibility and acceptability benchmarks: (a) \>70% enrollment of eligible participants, (b) \>70% retention, (c) \>75% adherence and data collection, (d) \>70 out of 100 usability score, (e) \>5 out of 7 satisfaction score, (f) \>average 5 on the perceived benefits score, and (g) \>3 out of 4 fidelity score. * Specific Aim 2. To assess preliminary efficacy of a 5-week online expressive storytelling intervention. * Hypothesis 2: AYA participants will report lower psychosocial distress, higher health-related quality of life, and higher well-being scores postintervention.

Who can participate

Age range15 Years – 25 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓.2 Patients must have any type of histologically or cytologically confirmed malignancy during adolescence or young adulthood.
✓.3 Patients may be at any stage of the cancer trajectory. Participants can be enrolled beginning one month after an initial cancer diagnosis.
✓.4 Patients must be cognitively intact.
✓.5 Patients must have access to the internet using their own electronic devices (e.g., laptop, desktop, tablet PC, smartphone).
✓.6 Ability to speak, write, read, understand English.

Exclusion criteria

✕.2 Patients who show their unwillingness to participate in the program by their actions (e.g., providing false information, just giggling rather than answering questions, increases in aggression or anxiety) can be discussed to make a decision about honoring their desire to withdraw from participation.

What they're measuring

Change in Secure Flourish Measure (Adolescent Version)

Timeframe: Day 0, Day 35

Change in Secure Flourish Measure (Adult Version)

Timeframe: Day 0, Day 35

Change in Herth Hope Index Scale

Timeframe: Day 0, Day 35

Change in Perceived Social Support from Health Care Professionals

Timeframe: Day 0, Day 35

Change in Self-transcendence Scale

Timeframe: Day 0, Day 35

Change in Patient-Reported Outcomes Measurement Information System (PROMIS) 29 v. 2.1 (Adult Version)

Timeframe: Day 0, Day 35

Change in Patient-Reported Outcomes Measurement Information System (PROMIS) 25 v. 2.0 (Adolescent Version)

Timeframe: Day 0, Day 35

Satisfaction Survey

Timeframe: Day 35

Trial details

NCT IDNCT04855487

SponsorVanderbilt University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-04-30

View on ClinicalTrials.gov More Pediatric Cancer trials

Plain-language summary

Who can participate

Age range15 Years – 25 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓.2 Patients must have any type of histologically or cytologically confirmed malignancy during adolescence or young adulthood.
✓.3 Patients may be at any stage of the cancer trajectory. Participants can be enrolled beginning one month after an initial cancer diagnosis.
✓.4 Patients must be cognitively intact.
✓.5 Patients must have access to the internet using their own electronic devices (e.g., laptop, desktop, tablet PC, smartphone).
✓.6 Ability to speak, write, read, understand English.

Exclusion criteria

✕.2 Patients who show their unwillingness to participate in the program by their actions (e.g., providing false information, just giggling rather than answering questions, increases in aggression or anxiety) can be discussed to make a decision about honoring their desire to withdraw from participation.

What they're measuring

Change in Secure Flourish Measure (Adolescent Version)

Timeframe: Day 0, Day 35

Change in Secure Flourish Measure (Adult Version)

Timeframe: Day 0, Day 35

Change in Herth Hope Index Scale

Timeframe: Day 0, Day 35

Change in Perceived Social Support from Health Care Professionals

Timeframe: Day 0, Day 35

Change in Self-transcendence Scale

Timeframe: Day 0, Day 35

Change in Patient-Reported Outcomes Measurement Information System (PROMIS) 29 v. 2.1 (Adult Version)

Timeframe: Day 0, Day 35

Change in Patient-Reported Outcomes Measurement Information System (PROMIS) 25 v. 2.0 (Adolescent Version)

Timeframe: Day 0, Day 35

Satisfaction Survey

Timeframe: Day 35